Population Pharmacokinetic and Exposure-Response Analysis of Weekly Teriparatide in Osteoporosis Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Population Pharmacokinetic and Exposure-Response Analysis of Weekly Teriparatide in Osteoporosis Patients

Published:2017-06-14 Issue:12 Volume:57 Page:1545-1553
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Ose Atsushi¹,Serada Masashi¹,Yamashita Keiko¹,Tsurui Kazuyuki²,Tanigawara Yusuke³

Affiliation:

1. Development Planning; Clinical Development Center; Asahi Kasei Pharma Corporation; Chiyoda-ku Tokyo Japan

2. Laboratory for Safety Assessment and ADME; Pharmaceuticals Research Center; Asahi Kasei Pharma Corporation; Shizuoka Japan

3. Department of Clinical Pharmacokinetics and Pharmacodynamics; Keio University School of Medicine; Shinjuku-ku Tokyo Japan

Funder

Asahi Kasei Pharma Corporation

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference30 articles.

1. Randomized Teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk;Nakamura;J Clin Endocrinol Metab,2012

2. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH;Jilka;Bone,2007

3. The role of the liver and kidneys in the pharmacokinetics of subcutaneously administered teriparatide acetate in rats;Serada;Xenobiotica,2012

4. Once-weekly teriparatide reduces the risk of vertebral fracture in patients with various fracture risks: subgroup analysis of the Teriparatide Once-Weekly Efficacy Research (TOWER) trial;Nakano;J Bone Miner Metab,2014

5. Vertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trial;Sugimoto;Curr Med Res Opin,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Osteodystrophy: Clinical Management;Endocrinology;2023-12-19

2. Effect of teriparatide on ligamentum flavum mesenchymal stem cells isolated from patients with ossification of the posterior longitudinal ligament;Journal of Pharmacological Sciences;2021-01

3. Talazoparib Exposure‐Efficacy Analysis in Patients With Advanced Breast Cancer and Germline BRCA1/2 Mutations in the EMBRACA Trial;The Journal of Clinical Pharmacology;2020-05-28

4. Population Pharmacokinetic Analysis of the Cathepsin K Inhibitor Odanacatib: Insights Into Intrinsic and Extrinsic Factor Effects on Exposure in Postmenopausal and Elderly Women;The Journal of Clinical Pharmacology;2020-04-17

5. Safety Profiles, Pharmacokinetics, and Changes in Bone Turnover Markers After Twice‐Weekly Subcutaneous Administration of Teriparatide in Healthy Japanese Postmenopausal Women: A Single‐Blind Randomized Study;Clinical Pharmacology in Drug Development;2019-03-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3